Shares of Triller Group (ILLR) cratered another 16.6% to $1.76 on July 7, extending a brutal selloff that has slashed the stock by more than 53% from its $3.77 close on June 29 — just four trading sessions ago. The decline began immediately after the company executed a flurry of corporate actions in late June, and the market's message is unambiguous: investors aren't buying what management is selling.
A Reverse Split Designed to Save the Listing Triggered the Opposite Reaction. Triller effected a 1-for-10 reverse stock split on June 25, 2026 to support Nasdaq listing compliance and broaden potential investor access.
The company had received a Nasdaq Hearings Panel exception until June 30 to regain compliance with the minimum bid price rule, requiring a $1.00+ closing bid for 10 consecutive business days or face potential suspension and delisting. While the split mathematically boosted the per-share price, the relentless post-split selling suggests shareholders view it as a last resort rather than a sign of strength. At $1.76 and falling, the stock is drifting dangerously back toward levels that could reopen compliance questions.
A $300 Million Fundraising Plan Just Hit a Wall. Shareholders approved potential private placements including a PIPE financing of up to $300 million, covering 200 million to 300 million shares at prices between $1.00 and $1.50 per share. But that plan suffered a serious blow: Nasdaq has advised the company that it will not recognize this omnibus authorization as sufficient for compliance with Nasdaq's shareholder approval rules.
The company has not entered into any definitive financing agreement and has not issued any securities under the authorization since the annual meeting. In plain terms, the company's primary tool for raising hundreds of millions in fresh cash is in limbo.
Management's Spin Can't Outrun the Numbers. CEO Wing-Fai Ng issued a public letter on June 25 insisting that " the reverse split is not the story of this Company. " Triller described 2025 as a reset year and 2026 as a monetization year, highlighting over $12 million spent on rebuilding reporting, audit, and governance. Yet the stock has done nothing but decline since. With a market capitalization of just $46.96 million and a "WEAK" overall financial health score (prior to the split), investors appear skeptical that promises of disciplined capital allocation can be delivered by a company still fighting to remain listed.
Dilution Risk Looms Large. Shareholders approved a reverse stock split, a 39,600,000-share equity incentive plan, and private placements for up to $300 million at $1.00–$1.50, all of which could materially dilute existing holders if fully utilized. Even if Nasdaq roadblocks are cleared, executing these raises at current prices would destroy shareholder value. Every tick lower makes the math worse.